New program aims to fight Cancer-Related weight loss with exercise and diet
NCT ID NCT05731076
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This clinical trial tests a 12-week self-management program that combines personalized exercise and nutrition counseling for lung cancer patients experiencing cachexia (unintended weight loss). The study involves 104 participants who will either receive the program or standard care. The goal is to see if the program improves nutritional status and is feasible for patients to follow at home.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- self-management support program (exercise and nutrition counseling)
- What this could lead to
- If successful, this program could help lung cancer patients with cachexia maintain or improve their nutritional status and quality of life.
- What could go wrong
- This is a small, early-stage trial with only 104 participants, so results may not apply to all patients. The program relies on patient adherence, which can vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 104 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2023
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Diagnosed lung cancer(ICD-10 code: C33-C34) 2. Body weight loss: body weight loss 2% before recruitment 2 months or body weight loss 5% before recruitment 6months. 3. Physician judged may do home exercise without supervisor. 4. Has smart phone and agree to use exercise associated application. 5. Agree to wear Xioami smart band as long as passible. 6. Conscious clear and communication. 7. Eastern Cooperative Oncology Group (ECOG) 0-1. Exclusion Criteria: 1. Participants with cardiovascular disease can't exercise without supervisor. 2. Diabetes Mellitus with blood sugar poor control. 3. Chronic obstructive pulmonary disease with dyspnea on exertion. 4. Platelets \< 50000mm3 due to disease or treatment. 5. Hemoglobin \<10mg/dl. 6. Recently stumble, severe pain, cognitive and behavior change. 7. Suspect or diagnosed brain metastasis. 8. Suspect or diagnosed bone metastasis. 9. Receive Nasogastric tube feeding or parenteral nutrition. 10. Physician judged can't do home exercise.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cachexia-anorexia syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Changhua Christian Hospital
Changhua, Changhua, 51052, Taiwan
-
Taipei Veterans General Hospital
Taipei, Taipei, 11219, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a common mental health drug prevent weight loss in cancer patients?
- Could better COPD care help lung cancer suspects breathe easier?
- New laser microscope could boost lung cancer detection during bronchoscopy
- New hope for tough lung cancer: targeted drug cocktails enter human testing
- Could a zapping the gut help beat immunotherapy resistance?
- New injection aims to help cancer patients eat and gain weight